.jpg?format=webp&quality=80&width=3840)
There is limited evidence on the best available treatment options for capillary malformations (CMs), mainly due to the absence of uniform outcome measures in trials on therapies. A Core Outcome Set (COS) enables standard reporting of trial outcomes, which facilitates comparison of treatment results. To develop a core outcome domain set (CDS), as part of a core outcome set (COS), for clinical research on CMs. The study recommends the CDS to be used as a minimum reporting standard in all future CM therapy trials.
Like
Save
Share